IRIS – Institutional Research Information System
IRIS è il sistema di gestione della ricerca dell’Università degli Studi di Milano-Bicocca.Il repository BOA è il modulo del sistema dedicato alla raccolta e alla disseminazione della produzione scientifica di Ateneo. Le pubblicazioni sono ricercabili per parola chiave attraverso il box nella barra orizzontale in alto oppure, mediante il pulsante Sfoglia, per "Afferenza", "Autore", "Titolo", "Tipologia" o "Settore scientifico-disciplinare".
IRIS contiene inoltre alcuni moduli dedicati alla registrazione dei progetti e dei contratti, e alla reportistica avanzata per le attività di valutazione della ricerca
EnglishBackground There are conflicting reports in the literature of the mortality risk among patients with psoriatic arthritis (PsA). The objective of this study was to examine the risk of mortality in patients with PsA compared with matched controls, patients with psoriasis and those with rheumatoid arthritis (RA). Methods A longitudinal cohort study was performed in a large UK medical record database, The Health Improvement Network, among patients with PsA, rheumatoid arthritis (RA) or psoriasis with data from 1994 to 2010. Unexposed controls were matched on practice and start date within the practice for each patient with PsA. Cox proportional hazards models were used to calculate the relative hazards for death. Results Patients with PsA (N=8706), RA (N=41 752), psoriasis (N=138 424) and unexposed controls (N=82 258) were identified; 1 442 357 person-years were observed during which 21 825 deaths occurred. Compared with population controls, patients with PsA did not have an increased risk of mortality after adjusting for age and sex (disease-modifying antirheumatic drug (DMARD) users: HR 0.94, 95% CI 0.80 to 1.10; DMARD non-users: HR 1.06, 95% CI 0.94 to 1.19) whereas patients with RA had increased mortality (DMARD users: HR 1.59, 95% CI 1.52 to 1.66; DMARD non-users: HR 1.54, 95% CI 1.47 to 1.60). Patients with psoriasis who had not been prescribed a DMARD had a small increased risk of mortality (HR 1.08, 95% CI 1.04 to 1.12) while those who had been prescribed a DMARD, indicating severe psoriasis, were at increased risk (HR 1.75, 95% CI 1.56 to 1.95). Conclusions Patients with RA and psoriasis have increased mortality compared with the general population but patients with PsA do not have a significantly increased risk of mortality.
Lazzaroni, M., Fredi, M., Andreoli, L., Brucato, A., Caporali, R., Caramaschi, P., et al. (2014). Systemic Vasculitis and Pregnancy: A Multicenter Study on Maternal and Neonatal Outcome of 66 Prospectively Followed Pregnancies. In EULAR 2014: Scientific Abstracts (pp.149-149).
| Citazione: | Lazzaroni, M., Fredi, M., Andreoli, L., Brucato, A., Caporali, R., Caramaschi, P., et al. (2014). Systemic Vasculitis and Pregnancy: A Multicenter Study on Maternal and Neonatal Outcome of 66 Prospectively Followed Pregnancies. In EULAR 2014: Scientific Abstracts (pp.149-149). |
| Tipo: | abstract |
| Carattere della pubblicazione: | Scientifica |
| Presenza di un coautore afferente ad Istituzioni straniere: | Si |
| Titolo: | Systemic Vasculitis and Pregnancy: A Multicenter Study on Maternal and Neonatal Outcome of 66 Prospectively Followed Pregnancies |
| Autori: | Lazzaroni, M; Fredi, M; Andreoli, L; Brucato, A; Caporali, R; Caramaschi, P; Doria, A; Gerosa, M; Guillevin, L; Inverardi, F; Lojacono, A; Meroni, P; Montecucco, C; Mosca, M; Motta, M; Ramoni, V; Sfriso, P; Sinico, R; Strigini, F; Tani, C; Tincani, A |
| Autori: | |
| Data di pubblicazione: | 2014 |
| Lingua: | English |
| Nome del convegno: | Annual European Congress of Rheumatology (EULAR) - June 11-14 |
| Rivista: | ANNALS OF THE RHEUMATIC DISEASES |
| Appare nelle tipologie: | 02 - Intervento a convegno |
File in questo prodotto:
http://hdl.handle.net/10281/140506
Copyright © 2020